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Abstract 
Objectives 
The aim of this study was to compare microvascular resistance under both baseline and 
hyperaemic conditions immediately after PCI of a CTO with an unobstructed reference 
vessel in the same patient 
Backgorund 
Microvascular dysfunction has been reported to be prevalent immediately after CTO PCI. 
However previous studies have not made comparison with a reference vessel. Patients with 
a CTO may have global microvascular and/or endothelial dysfunction, making comparison 
with established normal values misleading.  
Methods  
After successful CTO PCI in 21 consecutive patients, coronary pressure and flow velocity 
were measured at baseline and hyperaemia in distal segments of the CTO/target vessel and 
an unobstructed reference vessel. Haemodynamics including hyperaemic microvascular 
resistance(HMR), basal microvascular resistance(BMR) and instantaneous minimal 
microvascular resistance at baseline and hyperaemia were calculated and compared 
between reference and target/CTO vessels.  
Results 
After CTO PCI, BMR was reduced in the target/CTO vessel compared with the reference 
vessel: 3.58mmHg/cm/s vs. 4.94mmHg/cm/s, difference -1.36mmHg/cm/s(-2.33 to -
0.39,p=.008). We did not detect a difference in HMR: 1.82mmHg/cm/s vs. 2.01mmHg/cm/s, 
difference -0.20(-0.78 to 0.39,p=.49). Instantaneous minimal microvascular resistance 
correlated strongly with length of stented segment at baseline (r=0.63,p=.005) and 
hyperaemia (r=0.68,p=.002). 
Conclusions 
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Basal microvascular resistance is reduced in a recanalized CTO in the immediate aftermath 
of PCI compared to an unobstructed reference vessel; however hyperaemic microvascular 
resistance appears to be preserved. A longer stented segment is associated with increased 
microvascular resistance. 
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Introduction 
Even in the absence of flow-limiting epicardial coronary disease, an intact microvascular 
vasodilatory reserve is important in preventing myocardial ischaemia under stress1 and is 
associated with improved prognosis2. Transient target vessel microvascular dysfunction can 
occur in a proportion of patients in the immediate aftermath of PCI of non-occlusive 
coronary disease3,4 and has been reported to be more frequent in patients who have 
undergone PCI to a CTO5,6. Microvascular function in epicardially diseased vessels is related 
to unobstructed reference vessels in the same patient7, so the increased prevalence of 
microvascular dysfunction in this setting may simply reflect the greater burden of disease in 
patients with CTOs and represent a global phenomenon of microvascular or endothelial 
dysfunction. 
Microvascular resistance in the immediate aftermath of CTO PCI is not well 
described with respect to the now well established combined pressure and flow indices of 
microvascular resistance8. In addition, previous studies examining the effect of PCI to a CTO 
on microvascular function and coronary physiology have examined the target vessel, but not 
made comparison with a reference vessel5,6,9. The aim of this study was to describe the 
immediate effect of CTO PCI on the coronary microvasculature distal to the occlusion in 
comparison with an unobstructed reference vessel in the same patient. Using instantaneous 
measures of microvascular resistance we aimed to measure instantaneous minimal 
microvascular resistance to estimate maximal microvascular dilatation at rest and 
hyperaemia. We also investigated whether there was a relationship between post-PCI 
microvascular resistance and pre-PCI measures of collateral perfusion as well as procedural 
factors which might influence post-PCI microvascular resistance such as length of stented 
segment and means of CTO recanalization.  
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Methods 
Study population 
21 patients who underwent successful PCI to a CTO for symptoms of angina 
(Canadian Cardiovascular Society (CCS) class 1-3) were recruited consecutively in a single 
tertiary centre between July 2013 and June 2014. A CTO was defined as complete coronary 
occlusion of >3 months duration with TIMI grade 0 flow10. The presence of viable 
myocardium in the CTO territory was confirmed in all patients by myocardial perfusion 
scintigraphy(n=16, 76%), dobutamine stress echocardiography(n=1, 5%) or by the absence 
of a wall motion abnormality by echocardiography or left ventricular angiography without 
additional confirmation(n=4, 19%). Exclusion criteria were inability to provide consent, >1 
occluded vessel, disease of >50% angiographic severity in both other major epicardial 
coronary arteries, prior CABG with any patent grafts, left main stem stenosis considered to 
be haemodynamically significant and contra-indications to adenosine. Patient’s usual 
medications were continued and they were asked to abstain from caffeine for 48 hours prior 
to the procedure. 
Ethics 
The study protocol was approved by the local research ethics committee 
(12/YH/0360). All subjects provided written informed consent. 
Catheter laboratory protocol 
Dual arterial access was used for all procedures. Femoral venous access was 
obtained for central administration of adenosine and measurement of central venous 
pressure(CVP) at the beginning and end of the procedure using a catheter positioned in the 
right atrium. Patients were anti-coagulated with 100 U/kg of unfractionated heparin to 
maintain an activated clotting time of >300 seconds. After a 200μg bolus of intra-coronary 
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glyceryl trinitrate(GTN), iso-centred coronary angiograms of both non-target vessels were 
taken.  
The protocol for coronary haemodynamic assessment is summarised in figure 1. A dual 
sensor pressure-velocity 0.014” intracoronary wire (Combowire XT 9500, Volcano Corp, San 
Diego, CA)8, with pressure and Doppler sensors at its tip,  was connected to a ComboMap 
console (Volcano Corp) and used for haemodymamic measurements. PCI of the CTO was 
undertaken at the discretion of the treating interventional cardiologist using an antegrade 
or retrograde approach. Once access to the vessel lumen distal to the point of occlusion was 
achieved, prior to restoration of antegrade flow, a microcatheter was placed into the distal 
vessel to facilitate delivery of the Combowire. The Combowire was normalised to aortic 
pressure at the tip of the catheter alongside the microcatheter, removed, and passed 
through the microcatheter into the occluded segment and positioned in a vessel segment 
angiographically free of a significant stenosis. After administration of 100μg GTN in the 
vessel donating collaterals to the CTO vessel and once any hyperaemic response had settled, 
continuous recordings from the ComboMap were taken. Hyperaemia was achieved by 
central venous administration of adenosine at 140μg/kg/minute. Once steady state 
hyperaemia had been reached and a continuous recording of >20 beats taken, adenosine 
infusion was ceased. Samples were recorded at 200Hz and stored on disk for offline analysis. 
PCI success was defined as stenting of the target vessel with <30% residual stenosis 
and thrombolysis in myocardial infarction(TIMI) grade III flow. After successful PCI, The 
Combowire was normalised to aortic pressure at the tip of the catheter, advanced to the 
distal segment of   the target vessel at the point of measurement in the occluded segment 
prior to PCI and manipulated to obtain a good Doppler trace. After administration of 100μg 
intra-coronary GTN, once the hyperaemic response had settled, continuous recordings from 
the ComboMap were taken as described.  Haemodynamic measurements were then 
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repeated in each non-target vessel as described for the target vessel post-PCI, including 
repeated CVP measurement.  
Recorded data was analysed using dedicated custom software (Study Manager, 
Academic Medical Center, University of Amsterdam, The Netherlands).  
Angiographic assessment 
Maximal non-target vessel diameter stenosis(%) was calculated by two independent 
observers using quantitative coronary angiography(QCA)(GE Centricity CA1000, GE 
Healthcare) using the guiding catheter luminal diameter as reference. Mean values from 
both observers were used for analysis. The non-target vessel making the largest collateral 
contribution was identified, vessel collateral connection(CC) grade11 and modified Rentrop 
score12 were assessed by two independent observers blinded to haemodynamic 
measurements and agreed by consensus.  
The non-target vessel selected as the reference vessel was selected based upon an 
angiographic diameter stenosis severity of <50%. Where possible, the non-target vessel 
making the smallest collateral contribution to the CTO was selected. 
Data analysis 
Flow velocity was measured in cm/s, mean values are expressed as average peak 
velocity(APV) and instantaneous values as instantaneous peak velocity(IPV). Hyperaemic 
microvascular resistance(HMR) was calculated as Pd/APV under hyperaemic conditions and 
basal microvascular resistance(BMR) as Pd/APV under baseline conditions. FFR was 
calculated as (Pd-CVP)/Pa-CVP), using mean pressures taken over 5 cardiac cycles at stable 
hyperaemia13. Coronary flow reserve (CFR) was calculated as APV at steady state 
hyperaemia divided by APV at baseline, measured over 5 cardiac cycles. 
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In addition, we also investigated the instantaneous minimal microvascular resistance 
which was calculated by sampling instantaneous flow velocity and Pd from 25% into the 
diastolic period (taken from the dicrotic notch to the ECG R-wave), stopping at the onset of 
the qrs complex) over three beats.  It is during this period in the cardiac cycle that the absolute 
value and the variance of microvascular resistance have been shown to be minimal14. 
Instantaneous minimal microvascular resistance was then calculated as the  mean Pd/mean 
IPV taken during this period(figure 2). 
Collateral flow index (CFIp)  was calculated as for FFR, with Pd measured in the 
occluded segment of the artery, prior to restoration of antegrade flow. Collateral flow 
velocity reserve was calculated as for CFR with flow velocities in the occluded segment 
measured at rest and steady state hyperaemia. 
Measurement repeatability 
Based upon analysis of 26 repeated flow measurements at baseline and hyperaemia 
without any intervening treatment, coefficient of variation for average peak coronary flow 
velocity measurements was 17.4%. Analysis of 10 repeated measurements taken from 
repeated adenosine infusions gave a coefficient of variation for FFR, CFR and HMR of 3.6%, 
19.7% and 8.6% respectively. Using 10 repeated baseline measurements and 10 repeated 
hyperaemic measurements, the coefficient of variation for instantaneous minimal 
microvascular resistance was 12.8%. If just repeated baseline measurements were assessed 
it was 11.5% and if only hyperaemic measurements were assessed it was 14.0%. 
Statistical analysis 
Stata v.12(StataCorp, College Station, Texas) was used for statistical analysis. 
Continuous values are expressed as means±SD, or median(25th percentile-75th percentile) as 
appropriate. Continuous variables were compared using a paired t-test or Wilcoxon signed-
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rank test. Correlations were quantified using Pearson’s correlation coefficient. Probability 
values were 2-sided, and values of p<.05 considered significant. 
Results 
Of the 21 patients who underwent successful CTO PCI, mean age was 60.9±10.9 
years, 18 (86%) were male and mean LV ejection fraction was 57.3±10.2%. Median 
estimated duration of occlusion was 54 weeks (30-87) and all patients had Rentrop12 ≥2 and 
CC11 ≥1  grade collateralisation.  Drug-eluting stents were used for all procedures. 
Demographics, angiographic and procedural details are summarized in Table 1. 
Microvascular assessment 
Mean time in minutes from restoration of antegrade flow in the CTO vessel to post-
PCI microvascular assessment was 54.4±20.1 for the CTO/target vessel and 68.9±21.2 for 
the reference vessel. Post-PCI haemodynamic indices for the CTO vessel and reference 
vessel are detailed in Table 2. We did not demonstrate a significant difference in HMR, 
however BMR was significantly lower in the target vessel compared with the reference 
vessel: difference -1.36mmHg/cm/s(-2.33 to -0.39, p=.008). Although not well established, if 
an HMR is ≤2.0 is considered normal15, 14(67%) patients had a ‘normal’ target vessel HMR 
and 14(67%) patients had a ‘normal’ reference vessel HMR post CTO PCI.  If a CFR of ≥2 is 
considered normal1,2,7,16, 6(29%) patients had a ‘normal’ target vessel CFR and 10(48%) had 
a ‘normal’ reference vessel CFR. 
 Figure 2 depicts an example of the calculation of minimal instantaneous 
microvascular resistance at baseline and at hyperaemia. Figure 3 shows individual 
measurements for target/CTO and reference vessels. Under baseline conditions, 
instantaneous minimal microvascular resistance in the recently recanalized CTO vessel 
measured in mmHg/cm/s was 2.57±1.13 and was significantly lower when compared with a 
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paired unobstructed reference vessel, which measured 3.40±1.26; difference -0.83 (95% CI -
1.62 to -0.04, p=.04). We did not detect a statistically significant difference in minimal 
instantaneous microvascular resistance between target and reference vessels at 
hyperaemia(table 2). The reduction in minimal instantaneous microvascular resistance as a 
result of adenosine infusion was greater in the reference vessel: 2.10±1.07mmHg/cm/s than 
the target vessel: 1.26±0.68mmHg/cm/s; difference 0.84(95% CI 0.23 to 1.45, p=.009). 
Determinants of post-PCI microvascular function 
Any determinant of microvascular resistance should be related to the maximal 
vasodilatory capacity under either baseline or hyperaemic conditions, and therefore the 
minimal instantaneous microvascular resistance. We therefore examined the relationship 
between minimal instantaneous microvascular resistancve and invasively derived indices of 
pre-PCI collateral perfusion to the occluded segment, as well as length of stented segment 
(as a possible predictor of procedural microvascular injury). 
 It was possible to measure invasive indices of collateral function distal to the 
occlusion, prior to PCI in 19 of 21 patients, of which one was measured through a retrograde 
approach (CFIp : 0.50, Collateral flow velocity reserve: 1.02). We found no correlation 
between microvascular indices in the target vessel and invasive measures of collateral 
perfusion measured distal to the occlusion(figure 4).  
Target vessel minimal instantaneous microvascular resistance at both baseline and 
hyperaemia strongly correlated with length of stented segment in millimetres: baseline 
r=0.63, p=.005; hyperaemia r=0.68, p=.002 (figure 5). A similar relationship was found using 
mean values of microvascular resistance: BMR r=0.58, p=.005; HMR r=0.58, p=.005. There 
was no relationship between minimal instantaneous microvascular resistance and length of 
stented segment in the reference vessel: baseline r=0.21, p=.36; hyperaemia r=0.36, p=.11 
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Discussion 
 By conventional values of microvascular normality the results of this study, 
consistent with previous studies5,6, suggest that microvascular dysfunction is prevalent  
amongst recently recanalized CTOs. By the same definitions, this study demonstrates that 
high prevalence extends to global coronary microvascular dysfunction amongst patients 
with a CTO. We demonstrate that the microvasculature distal to a recently recanalized CTO 
behaves differently to the microvasculature in an angiographically unobstructed reference 
vessel in the same patient. In particular, the microvascular resistance under baseline 
conditions is lower in the recanalized CTO vessel relative to the reference vessel, however 
maximal vasodilatory capacity in response to adenosine appears to be preserved. There is a 
strong association between length of stented segment and increased microvascular 
resistance both under baseline conditions and in response to adenosine infusion. We were 
not able to demonstrate any relationship between invasively derived indices of 
collateralisation prior to recanalization of the CTO and target vessel microvascular 
resistance post PCI. 
Prevalance of microvascular dysfunction 
  If a CFR <2 is used to define microvascular dysfunction, 71% of CTO vessels had 
abnormal microvascular function after PCI. A larger study by Werner et al reported a CFR of 
<2 in 46% of a total of 120 patients6. However, by the same definition 53% of patients in our 
study had microvascular dysfunction (CFR<2) in an angiographically unobstructed reference 
vessel. Werner reported that in a sizeable proportion of patients (26% of 120) CFR did not 
return to ≥2 at 5 month follow up6. Our results would suggest that these patients are likely 
to have had global coronary microvascular dysfunction, possibly in conjunction with diffuse 
but non-obstructive atheroma and had it been measured, would also have had a CFR <2 in a 
reference vessel at the time of PCI.  
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If the definition of an HMR >2 is used to define microvascular dysfunction, we found 
a lower prevalence of 33% in CTO vessels. Interestingly, the prevalence of an HMR >2 was 
also 33% in reference vessels. We did not find a statistically significant difference in HMR or 
instantaneous minimal microvascular resistance between target/CTO and reference vessels. 
It might be argued that the increased prevalence of reference vessel microvascular 
dysfunction is due to a global effect of PCI17–19, however we have recently shown that in the 
non-target vessel donating least/no collaterals there is little change in indices of 
microvascular function before and after CTO PCI20. 
The HMR and CFR measure different aspects of the microvasculature. HMR 
measures the microvasculature’s maximal vasodilatory capacity, which does not seem to be 
reduced relative to a reference vessel. Except for in the event of idiosyncratic peri-
procedural microvasculature insult, maximal vasodilatory capacity appears to return to what 
is normal for the patient immediately after CTO PCI. This is consistent with previous findings 
that hyperaemic absolute coronary flow in the CTO myocardial segment is no different at 24 
hours compared with 6 months post PCI21;  and maximal coronary flow velocity is no 
different immediately after PCI compared with at 5 months follow-up6.  
CFR incorporates baseline flow and therefore basal microvascular tone. The most 
striking abnormality we demonstrate of the behaviour of the CTO/target vessel 
microvasculature relative to the reference vessel microvasculature is the significant relative 
reduction in basal microvascular resistance.   
Reduced basal microvascular tone 
   We report a significant reduction in BMR, minimal basal instantaneous 
microvascular resistance and the relative reduction in microvascular resistance in response 
to adenosine (as a result of lower basal microvascular resistance) in a recently recanalized 
CTO vessel compared with an unobstructed reference vessel (Table 2 & figure 4). This is in 
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keeping with previous reports of increased coronary flow velocity immediately after CTO 
PCI5,6, and is likely to represent impairment of the normal auto-regulatory mechanisms of 
the microvasculature to regulate coronary flow. Although collateral vessels are frequently 
sufficient to preserve myocardial viability22, they are seldom (if ever) sufficient to prevent 
ischaemia under stress23,24. This is most likely because the microvasculature distal to a CTO 
is in a state of maximal vasodilatation in order to preserve basal myocardial perfusion, and is 
unable to dilate any further25–27. Both endothelium dependent and independent 
vasodilatation have been shown to be impaired in CTO vessels in the immediate aftermath 
of PCI9,28, and return to normal at follow-up28. It is likely that the state of reduced basal 
microvascular tone that we demonstrate is related to the endothelial dysfunction of a 
chronically under-perfused vessel and we would expect it to normalise at a similar interval 
post-PCI. This state of reduced basal microvascular tone results in increased coronary flow 
under baseline conditions and therefore increased pressure gradient across any epicardial 
stenosis. Notwithstanding the dysfunctional nature of vasodilatory mechanisms in the 
recanalized epicardial segment of a CTO, optimization of the result using iFR14, a pressure 
based index of stenosis severity measured under baseline conditions, is therefore likely to 
lead to an erroneous result given the (most likely transient) increased basal flow. In the 
absence of microvascular embolization however, hyperaemic indices of stenosis severity are 
likely to be unaffected.       
Relationship with pre-PCI collateral perfusion 
We have not identified a relationship between indices of collateral perfusion prior to CTO 
PCI and target vessel/CTO microvascular resistance after PCI(figure 4). A previous study 
demonstrated greater coronary endothelial dysfunction in the recently recanalized segment 
of CTOs in patients who had previously had less well collateralised occluded segments as 
assessed by the CC grade9. However, this finding may have reflected individual patient’s 
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ability to form collaterals by arteriogenesis, which is an endothelium dependent process22. 
One might imagine that improved collateral perfusion prior to recanalization might result in 
less marked microvascular abnormalities post-recanalization. The effect of other variables, 
in particular the length of the stented segment on microvascular resistance makes this 
difficult to investigate further in such a small patient population.  
Relationship with length of stented segment  
 We demonstrate a strong relationship between length of stented segment and 
microvascular resistance both at baseline and hyperaemia with higher microvascular 
resistance associated with a longer stented segment(figure 4). It seems likely that this is 
related to increased risk of micro-embolization and microvascular injury as the treated 
segment increases in length. The finding is consistent with a previous study which 
demonstrated increased risk of peri-procedural myocardial infarction (MI4a) with a longer 
stented segment in non-occlusive disease29. Contemporary techniques of dissection/re-
entry tend to result in longer stented segments, but also involve greater disruption to the 
vascular architecture than a lumen-lumen approach which could conceivably lead to more 
distal embolization. The greater vascular disruption of the dissection re-entry approach 
might explain this finding; however the same trend with stent length seems to occur 
amongst the lumen-lumen group. In either case, it would appear that a dissection re-entry 
approach (usually involving a longer stented segment) is associated with peri-procedural 
microvascular impairment which may not be apparent angiographically (all study patients 
had TIMI III flow at the time of haemodynamic measurement). It remains to be seen if this 
finding has any implication with respect to clinical outcomes. 
 The total number of study participants was small with a low rate of diabetes. We 
have therefore not been able to examine clinical characteristic such as smoking, 
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hypertension and diabetes that might be related to microvascular dysfunction as previously 
reported5. 
Limitations 
This is a single centre study, with a small number of patients. However, it is the first 
to make comparison of microvascular resistance after CTO PCI in the target and an 
unobstructed reference vessel.  The study population had a preponderance of right 
coronary CTOs and the reference vessel was more commonly a branch of the left coronary 
artery. Although this could have introduced confounding into our results, it does not seem 
plausible that it could account for our major findings.   
By Protocol, target/CTO vessel haemodynamics were assessed earlier than the 
reference vessel, with a mean interval of 14.5 minutes between measurements. Although it 
would be preferable to have taken measurements at the same interval after restoration of 
antegrade flow, we consider it unlikely to have altered our results.  
We did not incorporate collateral flow into our calculation of microvascular 
resistance. However it has been shown previously that in vessels with an FFR >0.60, the 
effect of collateral flow on HMR is minimal30. All interrogated vessels in this study had an 
FFR well in excess of 0.60. 
Where possible we selected the vessel angiographically donating least/no collaterals 
to the CTO vessel. Receipt of collaterals rapidly diminishes after CTO PCI31,32 and collateral 
donation falls at a similar interval with little effect on the microvasculature of the non-target 
vessel donating least/no collaterals 20. It is plausible that the presence of minimal collaterals 
may have had some effect on our measurements, however we consider it unlikely to have 
altered our results significantly.   
We would imagine that microvascular resistance under baseline conditions in the 
CTO/target vessel would increase to a level similar to the reference level after an interval. 
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However, we did not repeat assessments at follow-up and further studies would be required 
to confirm and describe this.  
Conclusions 
   Microvascular resistance under baseline conditions is reduced in a recanalized CTO 
in the immediate aftermath of PCI when compared to an unobstructed reference vessel; 
however hyperaemic microvascular resistance appears to be similar. Although 
microvascular dysfunction is common in CTO vessels after recanalization, the dysfunction 
appears to be abnormal autoregulation of microvascular tone (or a continued hyperaemic 
response to coronary occlusion in spite of recent recanalization) with a preserved maximal 
vasodilatory capacity.  A longer stented segment is associated with increased microvascular 
resistance both under baseline conditions and at hyperaemia. The abnormal microvascular 
conditions in this setting should be considered prior to considering physiological lesion 
assessment in the immediate aftermath of CTO PCI.    
Clinical implications 
Microvascular resistance under baseline conditions remains abnormally low approximately 1 
hour after recanalization of a CTO, but maximal vasodilatory capacity appears to remain unchanged. 
If phyisiological lesion assessment is considered in this setting, the use of ‘resting’ indices such as iFR 
are likely to overestimate lesion severity due to relative hyperaemia. Longer stented segments and 
dissection re-entry techniques may be associated with greater microvascular injury, larger studies 
are required to investigate this further and establish any clinical significance. 
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Figures 
 
Figure 1. 
Flowchart summarizing the order of haemodynamic measurements taken as part of the study 
protocol. RAP = right atrial pressure. 
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Figure 2.  
Assessment of minimal instantaneous microvascular resistance. Coronary haemodynamics 
measured in a recently recanalized right coronary artery. Instantaneous coronary pressure 
(top, Pa and Pd), flow velocity (middle) and derived microvascular resistance (bottom) under 
baseline conditions(left) and at maximal hyperaemia (right). The segments within red boxes 
represent the sampled period for minimal instantaneous microvascular resistance. 
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Figure 3.  
CTO/target vessel basal and hyperaemic microvascular resistance after PCI. Left graph: 
Instantaneous minimal microvascular resistance at baseline and hyperaemia for the 
CTO/target vessel (left) and an unobstructed reference vessel (right). Right graph: Using mean 
values, baseline and hyperaemic microvascular resistance (BMR and HMR) for the CTO/target 
vessel (left) and an unobstructed reference vessel (right). Error bars represent 95% 
confidence intervals.   
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Figure 4.  
Relationship between pre-PCI collateral perfusion and post-PCI microvascular resistance 
CTO/target vessel instantaneous minimal microvascular resistance at baseline (left) and 
hyperaemia right).  
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Figure 5.  
Relationship between length of stented segment in mm and CTO/target vessel instantaneous 
minimal microvascular resistance at baseline (left) and hyperaemia (right). Circles represent 
an antegrade lumen-lumen approach, triangles: antegrade dissection re-entry and squares: 
retrograde dissection re-entry. 
 
 
 
 
 
